Медицинская помощь больным с острым коронарным синдромом на догоспитальном этапе

Embed Size (px)

DESCRIPTION

Медицинская помощь больным с острым коронарным синдромом на догоспитальном этапе. Проф. С.Н. Терещенко 16.09.08. Определение острого коронарного синдрома. Любая группа клинических признаков, - PowerPoint PPT Presentation

Text of Медицинская помощь больным с острым коронарным...

  • . .. 16.09.08

  • , , 2004,

  • ST ST

    ST QQ

  • , ,

  • / ( )

  • , ( ) .

  • . .

  • 1.

    2.

    3. :

  • 221370510152025% .Lee T., Cook E., et al. 1985

  • , ,

  • . . .

  • ( ) , , .

  • . . . ST.

  • ST( )

    ST( , )

    ( , )

    ST

    6

    STEur Heart J 2002; 23: 1809-40

  • . . . . .

  • ,

  • ST .

  • 0,4 / >90 , 5 ( , ) / 2-4 + 2-8 5-15 4-8 + 2 5 3-5 \ >90 mm Hg, , , 0,4 / >90 03

  • ST .

  • www.acc.org12,56,45,32,0 ST- p=0,0005p=0,00055 -2 1 %n=2488n=2629

  • , ST (, )

  • Eur Heart J 2002; 23: 809-40. Circulation 2002; 106: 893-1900. Chest 2004; 126: 513S-548S. Eur Heart J 2004; 25: 166-81. 2004, . ST.

    , ST (2002 .)75-150100 I () , ST (2002 .)162-32575-160I () , ST (2004 .)250-50075-325, 75-160 (150)- , (2004 .)160-30075-100I () (2004 .)160-32575-162I ()

  • ST 48-72 / /

    ST

    ST ( >6 ) 6-12 2 8 ( )

  • Circulation 2003; 107: 966720,000,020,040,060,080,100,120,140369129,3%11,4%- , , , + 34%=0,003 92%, 54% ST CURE (n=12 562)

  • ST ( 300 , 75 /) Eur Heart J 2002; 23: 809-40. Circulation 2002; 106: 893-1900. Chest 2004; 126: 513S-548S. 2004, . Eur Heart J 2005; 26: 804-47

    (2002 .) 9 12 I () (2002 .) 1 9 I ()I () (2004 .) 1 - (2004 .) 9-12 I () , (2005 .) 9-12 I ()

  • ST

  • 14 5,112,813,932,705101520253035 1997 2000 . 1997 2005 . >50 *Projected populations of people aged over 50 years, and estimated prevalence of myocardial infarction and ischemic stroke cumulated in 14 countries: Belgium, Canada, Denmark, Finland, France, Germany, Italy, Netherlands, Norway, Spain, Sweden, Switzerland, UK, USAGuillot F, Moulard O. Circulation 1998; 98(abstr suppl 1): 1421205 222.2 9.1 10.7

  • .. 5 - 2,8%

  • 2006

  • ST 11.10.2007

  • , , , ,

  • % status anginosus status asthmaticus status gastralgicus 897121-65,610,56,714,3-2,9616 105 ..

  • , Q- , (/ ST-, ) , ( , ) . ST . 2007 . .

  • 100

  • (%) :InTIME II: 30 * 0.71.31.93.96.512.015.021.024.032.0010203040012345678>8Morrow DA et al. Circulation 2000; 102: 2031-20371) 65-74 / 75 2) < 100 3) > 100 4) Killip II-IV 5) 6) 7) < 67 8) > 4

    *

  • ST

  • , , ,

    ( ) ST ST , . , , , ,

  • , , , , , ( ), , -

    , ST ST

  • 1. ;2. ;3. - , ;4. , ;5. / ;6. ;7. ;8. ;9. ;10. ;11. ,

  • ( ) ST ST .1. .2. , 250 .3. 300 .4. / , , , .5. b-. / , , / , , , . . - 600 .

  • 0,4 / >90 , 5 ( , ) / 2-4 + 2-8 5-15 4-8 + 2 5 3-5 \ >90 mm Hg, , , 0,4 / >90 03

  • O2
  • / () 0,4 3- 5 / (5-200 /, 10% , 30% ) 30 Hg 100
  • Lancet 1995; 345: 669-85 - (n=81 908)9 , 11 , /GISSI-3ISIS-4 5,5% =0,03

  • % 30 Placebo Aspirin SK Aspirin + SK

  • ST , , . 300 , 75 75 /. .

    75 / 4 . 1 . . ST . 2007 .

  • CLARITY + COMMIT: + CLARITY-TIMI 28, CLopidogrel as Adjunctive Reperfusion TherapY-Thrombolysis In Myocardial Infarction Study 28; COMMIT/CCS-2, ClOpidogrel and Metoprolol in Myocardial Infarction Trial (Second Chinese Study); CV, cardiovascular; LD-ASA, low-dose acetylsalicylic acid; MI, myocardial infarction.1. Sabatine MS, et al. N Engl J Med 2005;352:117989. 2. COMMIT Collaborative Group. Lancet 2005;366:160721. 36% , - CLARITY-TIMI 28 (p
  • . , , . ST . . ST . 2007 .

  • 65* 1000 37*29*18*0-1 1-2 2-3 3-6 Lancet 1996; 348: 771-5 35 26*12-24 n=50 246*
  • SKPTCA : =

  • ST
  • USIC 2000: Danchin et al. Circulation 2004; 110: 19091915.153.38.06.712.20510 (%).

  • WEST, n=304%EHJ, 2006; 27, 1530-1538

  • FAST-MI 2005N. Danchin, ESC Congress, 2007 30

  • - () , . . .

    , / 15-20 ., 12 / 3 12 / ST ( ) ST 1 , / 30 ( ), ( )

  • : _____________________________() ( , ) : / ( ) _________________________() ____________ _________ _____________

    35 40 180 . . 110 . . , 15 . . () ( - ) ( 10 ) - 2 ; 3 . ( .. ) / , - , ,

  • 12 , ST 0,1 mV, 2- 2- , . ( R ST V1-V4 T). . ST . 2007 .

  • ; , 3- ; , ; ; ( ); 3 ; , , - , . ST . 2007 .

  • : , , ; - . >180 .., . >110 . ); 3 ; , ; ( 10 ), - , 3- ; ( 2-4- ) ; , ; 5 ; ; ; ( , ).

  • . ST . 2007 .

  • (rescue) (primary) (facilitated) 200 , 35-40 . 75 ) . ST . 2007 .

  • , :

    3

    ( , , );

    90 , 60

  • , : , 75 , 90 ; : , , ; : ; : ST >3 .

  • . ST . 2007 . . / 60 / ( 4000 ), 12 // ( 1000 /). ( 1,5-2 ). 3, 6, 12 24 . 6 . 24-48 . .\ 70-100 / ( IIb/IIIa ). , 300-350 . 2-5 , 20-30 . 20 /. . :/ 7500-12500 2 5000 3 ( ).

  • . ST . 2007 . / 30 , / 1 / 2 8- . 2 / 100 . 75 \ . 0,75 / ( 2 75 ). 30 / / 1 / . / 1 / 8 , . 8-12 , / 0,3 /. . 40 1 .

  • - / - (n=52 411)Lancet 2005; 366: 1622-32

  • /2.9100%50%www.cardiosite.ru-: 59 GRACE (2000-1 .)N=2806C ST 50.3% ST 49.7%C ST ST0%/4.3%100%50%0%1234123420.254.355.650.712.25460.354.51234. 7 24 . .

  • C / / \ -

  • - ST

    1- / 5 2-3 2 ; 15 ./ 0,1 / 2-3 2-3 ; 4 . / 0,05-0,1 // 0,05 // 1015 0,3 //; 0,5 / 25 . -, .

  • 10

    , , , O2

    /

    12-

    , , , , Hb, Ht, , ,

    O2 4-8 / O2 >90% ( ): 160-325 , 300 / 500

    300 , 90, , ,

    2-4 / , !!!

    Before moving to the fruits of your labor in NRMI, Ill briefly show the performance of the score in the derivation set from InTIME II.

    As you can see in this figure, the Risk Score showed a strong association with mortality at 30 days, with a significant graded increase in mortality with rising Risk Score ranging from less than 1% to over 30% mortality in those with the highest scores. As displayed along the bottom axis, the distribution of patients was such that at the high end, a score >5 identified 12% of patients with a mortality risk at least 2-fold higher than the mean for the population. In contrast, the 12% of patients with a risk score of zero had a mortality rate